|
MRK's Net Income Growth by Quarter and Year
Merck And Co Inc 's Net Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| MRK Net Income (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
| IV Quarter |
December |
-
|
3,759.00
|
-2,092.00
|
2,364.00
|
| III Quarter |
September |
-
|
4,571.00
|
2,945.00
|
1,907.00
|
| II Quarter |
June |
-
|
1,546.00
|
3,010.00
|
2,644.00
|
| I Quarter |
March |
4,313.00
|
3,186.00
|
3,219.00
|
2,862.00
|
| FY |
|
4,313.00
|
13,062.00
|
7,082.00
|
9,777.00
|
| MRK Net Income first quarter 2022 Y/Y Growth Comment |
Merck and Co Inc reported Net Income improvement of 35.37% year on year in the first quarter 2022, to $ 4,313.00 millions, this is lower than Merck And Co Inc 's recent average Net Income rise of 41.5%.
Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 19 other companies have achieved higher Net Income growth. While Merck And Co Inc ' s Net Income rise of 35.37% ranks overall at the positon no. 671 in the first quarter 2022.
|
| MRK Net Income ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
- |
- |
32.96 % |
| III Quarter |
September |
- |
55.21 % |
54.43 % |
-2.6 % |
| II Quarter |
June |
- |
-48.64 % |
13.84 % |
54.08 % |
| I Quarter |
March |
35.37 % |
-1.03 % |
12.47 % |
286.23 % |
| FY |
|
- |
84.44 % |
-27.56 % |
57.87 % |
MRK Net Income (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
-17.76 % |
- |
23.96 % |
| III Quarter |
September |
- |
195.67 % |
-2.16 % |
-27.87 % |
| II Quarter |
June |
- |
-51.48 % |
-6.49 % |
-7.62 % |
| I Quarter |
March |
14.74 % |
- |
36.17 % |
60.97 % |
| FY (Year on Year) |
|
- |
84.44 % |
-27.56 % |
57.87 % |
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 797.92 % |
41.5 % |
-89.24 % |
| IV. Quarter |
|
(Sep. 30, 2010) |
|
|
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 797.92 % |
41.5 % |
-89.24 % |
| IV. Quarter |
|
(Sep. 30, 2010) |
|
| Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Merck And Co Inc 's Q/Q Net Income Growth
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 770.19 % |
28.16 % |
-94.94 % |
| IV. Quarter |
|
|
| MRK's I. Quarter Q/Q Net Income Comment |
Merck and Co Inc achieved in the I. Quarter 2022 below company average Net Income rise of 14.74% quarter on quarter, to $ 4,313.00 millions.
Although the I. Quarter 2022 Net Income sequential growth was lower than the average , it has been still encouraging news, as the I. Quarter improvement, outshines the % Net Income growth in the I. Quarter a year ago
Within Major Pharmaceutical Preparations industry 19 other companies have achieved higher Net Income quarter on quarter growth. While Merck And Co Inc 's Net Income growth quarter on quarter, overall rank is 863. |
|
|
|
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 770.19 % |
28.16 % |
-94.94 % |
| IV. Quarter |
|
|
| MRK's I. Quarter Q/Q Net Income Comment |
Merck and Co Inc achieved in the I. Quarter 2022 below company average Net Income rise of 14.74% quarter on quarter, to $ 4,313.00 millions.
I. Quarter 2022 MRK's results appear to be paradoxical, albeit beneath the average, yet it demonstrates real recovery compare to the % in the same quarter a year ago.
Within Major Pharmaceutical Preparations industry 19 other companies have achieved higher Net Income quarter on quarter growth. While Merck And Co Inc 's Net Income growth quarter on quarter, overall rank is 863. |
|
Merck And Co Inc 's 12 Months Net Income Growth Year on Year
Net Income TTM Growth |
12 Months Ending
(Mar 31 2022) |
12 Months Ending
(Dec 31 2021) |
12 Months Ending
(Sep 30 2021) |
12 Months Ending
(Jun 30 2021) |
12 Months Ending
(Mar 31 2021) |
| Cumulative Net Income 12 Months Ending |
$ 14,189.00 |
$ 13,062.00 |
$ 7,211.00 |
$ 5,585.00 |
$ 7,049.00 |
| Y / Y Net Income Growth (TTM) |
101.29 % |
84.44 % |
-37.5 % |
-46.81 % |
-30.44 % |
| Year on Year Net Income Growth Overall
Ranking |
# 402 |
# 531 |
# 1084 |
# 1780 |
# 1064 |
| Seqeuential Net Income Change (TTM) |
8.63 % |
81.14 % |
29.11 % |
-20.77 % |
-0.47 % |
| Seq. Net Income Growth (TTM) Overall
Ranking |
# 652 |
# 125 |
# 257 |
# 2142 |
# 1674 |
| Cumulative Net Income growth
Comment |
Merck And Co Inc saw improvement in Net Income growth trend, posting cumulative 12 months Net Income growth of 101.29% year on year, to $ 14,189 millions if the fiscal year would have ended in Mar 31 2022.
Merck And Co Inc 's trailing twelve months Net Income growth was higher than company's average 37.38% and higher than 84.44% growth in Dec 31 2021.
But from twelve months ended Dec 31 2021 growth rate was beneth at 8.63 % from $13062 millions reported in twelve months ending a quarter Dec 31 2021.
In spite of, this was confirmation of strength, as the typical Q/Q TTM growth lays at 8%.
The growth was even more impressive from the previous reporting period exhibited at 8.63 % increase from $13062 millions in twelve months ending a quarter before.
Within the Healthcare sector 27 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 402, from total ranking in previous quarter at 531. |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
146.86 % |
8 % |
-87.73 % |
|
|
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
575.58 % |
37.38 % |
-92.46 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 16 |
| Sector |
# 46 |
| S&P 500 |
# 652 |
|
| Cumulative Net Income growth
Comment |
Merck And Co Inc saw improvement in Net Income growth trend, posting cumulative 12 months Net Income growth of 101.29% year on year, to $ 14,189 millions if the fiscal year would have ended in Mar 31 2022.
Merck And Co Inc 's trailing twelve months Net Income growth was higher than company's average 37.38% and higher than 84.44% growth in Dec 31 2021.
But sequential growth rate was less at 8.63 % from $13062 millions recorded in the period from Dec 31 2021 to Mar 31 2021 Ben Surname added on.
Still this was evidence of positive momentum, as the average sequential gain lays at 8%.
The momentum was even more impressive from the previous reporting period exhibited at 8.63 % rise from $13062 millions in twelve months ending a quarter before.
Within the Healthcare sector 27 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 402, from total ranking in previous quarter at 531. |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
146.86 % |
8 % |
-87.73 % |
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
575.58 % |
37.38 % |
-92.46 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 16 |
| Sector |
# 46 |
| S&P 500 |
# 652 |
|
59.47%